About
Spinal Cord Treatment Technology
Neurocords is developing regenerative therapies for spinal cord injuries. Its focus is on a novel cellular therapy platform aimed at restoring function following spinal cord injuries.
Identity
| Name | Neurocords |
|---|---|
| Slug | neurocords |
| Type / kind | startup |
| Source _id | lw5y5dOBUoWlhyt7n40JnjRvkIEXtecnQ95gA6sNOYInCKO8Xt5qiA |
Status
| Status | acquired |
|---|---|
| Status reason | Acquired by Orgenesis on Mar, 2025 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | HaRakevet St 58, Tel Aviv-Yafo, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Business models
B2B
Funding
| Total raised | — |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}